At a glance
- Since making our first grants in South Africa in 1999, we have been committed to addressing issues such as the country’s high rates of HIV and tuberculosis (TB), social inequality, and inadequate water and sanitation infrastructure.
- South Africa has less than 1 percent of the world’s population, but it accounts for 18 percent of the world’s HIV infections and HIV-related deaths and 6 percent of the world’s TB infections and 2.5 percent of global TB-related deaths.
- South Africa’s future depends on the country’s ability to apply its scientific expertise and other resources to address challenges in health, social inequality, and lack of opportunity for the growing youth population.
South Africa is among the most prosperous, innovative countries in Africa, and its R&D sector is critical to the future of the entire continent and scientific progress globally. But the benefits of this innovation and prosperity are spread unevenly. The country’s future depends on its ability to apply these assets to address challenges in health, social inequality, and lack of opportunity for the growing youth population.
We work with the South African government and other partners to help the country make progress in the following areas:
- Development of new drugs, diagnostics, and vaccines for HIV and TB
- Delivery of proven HIV prevention and treatment programs
- Delivery of TB prevention and treatment interventions
- Technical assistance and support for programs that aim to improve family health, agriculture, and water, sanitation, and hygiene
More about our work in Africa
Our office in Johannesburg is the foundation's regional headquarters in Africa.
A brief overview of our priorities in Africa.
Read the latest stories, research, and news from across the foundation and subscribe to our weekly newsletter, The Optimist.